AI is changing the field of synthetic biology and how we engineer biology. It’s helping engineers design new ways to design genetic circuits — and it could leave a remarkable impact on the ...

Synthetic biology company Ginkgo Bioworks tops $4 billion valuation with investment from fund giant T. Rowe Price. That's a big win for the company's five founders, whose stakes are now worth an ...

GEN’s first-ever A-List for synthetic biology ranks the five largest public companies by their 2020 revenues, and the five largest private companies by the total capital they have raised.

Synthetic biology won't get very far without robust digital tools that make it easier to design, test, and simulate new DNA constructs. Autodesk is one company leading the charge for this critical ...

Dublin, March 28, 2025 (GLOBE NEWSWIRE) -- The Synthetic Biology Market - A Global and Regional Analysis: Focus on Tools, Application, Technology, a. Tuesday, 02 January 2024 12:17 GMT.

Per Grandview research, the global synthetic biology market size was valued at $16.22 billion in 2024 and is projected to witness a CAGR of 17.30% from 2025 to 2030.

Codexis (NASDAQ: CDXS) is a synthetic biology company making enzymes to produce all kinds of products. Their claim to fame is their CodeEvolver platform they use to create and optimize new enzymes.